DOSSIER · 13F Holders · Q2 2026
Crescent Biopharma Inc
2 institutions still hold Crescent Biopharma Inc as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 38000Q201·2 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
2 institutions reported Crescent Biopharma Inc in Q2 2026. Boxer Capital Management, LLC leads at 95.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.